Central Pharmaceutical Joint Stock Company No3: Net profit grew 8.3% year-over-year in Q1 2025, with improved cash flow and margins

About this update from Central Pharmaceutical Jsc No. 3

Q1 2025 saw net profit rise 8.3% year-over-year to VND 23.86 billion, despite an 11.3% drop in net revenue. Operating cash flow turned positive, and cost controls improved margins. Original document: This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.

View stock analysis, news, and events for Central Pharmaceutical Jsc No. 3